Stockreport

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that [Read more]